ZHYBF (Zhong Yuan Bio-Technology Holdings) Beneish M-Score: 0.00 (As of Sep. 09, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ZHYBF Zhong Yuan Bio-Technology Holdings Ltd ZHYBF
12 GF Score
Price $2.02
View Full Analysis

What is Zhong Yuan Bio-Technology Holdings Beneish M-Score?

Zhong Yuan Bio-Technology Holdings ZHYBF -100.00% 12 Beneish M-Score is 0.00 as of Sep. 09, 2026. GuruFocus rates ZHYBF with a GF Score™ of 12/100.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

The historical rank and industry rank for Zhong Yuan Bio-Technology Holdings's Beneish M-Score or its related term are showing as below:

During the past 9 years, the highest Beneish M-Score of Zhong Yuan Bio-Technology Holdings was 0.00. The lowest was 0.00. And the median was 0.00.

Zhong Yuan Bio-Technology Holdings Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Zhong Yuan Bio-Technology Holdings's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zhong Yuan Bio-Technology Holdings Beneish M-Score Chart

Zhong Yuan Bio-Technology Holdings Annual Data
Trend Dec16 Dec17 Dec18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only 145.95 -3.95 0.00 1.79 1.36

Zhong Yuan Bio-Technology Holdings Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 1.79 0.00 1.36

ZHYBF vs CLNN, JVA, STCB: Beneish M-Score Comparison

For the Packaged Foods subindustry, Zhong Yuan Bio-Technology Holdings's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zhong Yuan Bio-Technology Holdings Beneish M-Score vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Zhong Yuan Bio-Technology Holdings's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Zhong Yuan Bio-Technology Holdings's Beneish M-Score falls into.


ZHYBF
12GF Score
Zhong Yuan Bio-Technology Holdings Ltd ZHYBF
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zhong Yuan Bio-Technology Holdings Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Zhong Yuan Bio-Technology Holdings for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 3.0315+0.528 * 1.0036+0.404 * 0.6724+0.892 * 1.3698+0.115 * 1.3228
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.3685+4.679 * 0.333333-0.327 * 0.8102
=1.36

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar24) TTM:Last Year (Mar23) TTM:
Total Receivables was $1.47 Mil.
Revenue was $2.28 Mil.
Gross Profit was $2.07 Mil.
Total Current Assets was $2.03 Mil.
Total Assets was $3.17 Mil.
Property, Plant and Equipment(Net PPE) was $0.58 Mil.
Depreciation, Depletion and Amortization(DDA) was $0.12 Mil.
Selling, General, & Admin. Expense(SGA) was $1.31 Mil.
Total Current Liabilities was $2.48 Mil.
Long-Term Debt & Capital Lease Obligation was $0.90 Mil.
Net Income was $0.30 Mil.
Gross Profit was $-0.01 Mil.
Cash Flow from Operations was $-0.75 Mil.
 Total Receivables was $0.35 Mil.
Revenue was $1.66 Mil.
Gross Profit was $1.52 Mil.
Total Current Assets was $1.04 Mil.
Total Assets was $2.13 Mil.
Property, Plant and Equipment(Net PPE) was $0.53 Mil.
Depreciation, Depletion and Amortization(DDA) was $0.16 Mil.
Selling, General, & Admin. Expense(SGA) was $2.60 Mil.
Total Current Liabilities was $2.21 Mil.
Long-Term Debt & Capital Lease Obligation was $0.61 Mil.

1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(1.47 / 2.278) / (0.354 / 1.663)
=0.645303 / 0.212868
=3.0315

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(1.518 / 1.663) / (2.072 / 2.278)
=0.912808 / 0.90957
=1.0036

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (2.026 + 0.58) / 3.168) / (1 - (1.043 + 0.528) / 2.134)
=0.177399 / 0.263824
=0.6724

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=2.278 / 1.663
=1.3698

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(0.159 / (0.159 + 0.528)) / (0.123 / (0.123 + 0.58))
=0.231441 / 0.174964
=1.3228

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(1.311 / 2.278) / (2.597 / 1.663)
=0.575505 / 1.561636
=0.3685

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((0.904 + 2.483) / 3.168) / ((0.608 + 2.208) / 2.134)
=1.069129 / 1.319588
=0.8102

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(0.302 - -0.008 - -0.746) / 3.168
=0.333333

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Zhong Yuan Bio-Technology Holdings has a M-score of 1.36 signals that the company is likely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of 0.00 mean?
Zhong Yuan Bio-Technology Holdings (ZHYBF) has a Beneish M-Score of 0.00 as of Sep. 09, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Zhong Yuan Bio-Technology Holdings and its competitors.
Is Zhong Yuan Bio-Technology Holdings' Beneish M-Score too high?
Zhong Yuan Bio-Technology Holdings' current Beneish M-Score is 0.00. Overall, Zhong Yuan Bio-Technology Holdings has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Zhong Yuan Bio-Technology Holdings' Beneish M-Score compare to CLNN and JVA?
Zhong Yuan Bio-Technology Holdings' Beneish M-Score of 0.00 can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Consumer Packaged Goods company?
A good Beneish M-Score depends on the Consumer Packaged Goods industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Zhong Yuan Bio-Technology Holdings and its competitors. Zhong Yuan Bio-Technology Holdings's current Beneish M-Score is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhong Yuan Bio-Technology Holdings stock overvalued right now?
Zhong Yuan Bio-Technology Holdings (ZHYBF) has a current Beneish M-Score of 0.00. The current Beneish M-Score is 0.00. Zhong Yuan Bio-Technology Holdings' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Zhong Yuan Bio-Technology Holdings (ZHYBF), the current Beneish M-Score is 0.00 as of Sep. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Zhong Yuan Bio-Technology Holdings Business Description

Address 28 Queen’s Road East, Suite 901, Tesbury Centre, Wanchai, Hong Kong, HKG
Zhong Yuan Bio-Technology Holdings Ltd is engaged in the business of developing and marketing nervonic acid-based health supplements and sales of acer truncatum seedlings. The company has two reportable segments such as sales of health care supplements and technical supporting services. The company generates its revenue primarily from the sales of health care supplements.
12GF Score

Get the complete analysis for ZHYBF

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.02
Price